Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 12 open reading frame 42 (C12orf42) is a human gene located at cytogenetic band 12q23.2, encoding a soluble intracellular protein with predicted nuclear localization signals[2]. The protein contains a DUF4607 domain and possibly coiled-coil regions, but its molecular function is uncharacterized. C12orf42 is expressed in various tissues including immune organs (lymph node, spleen, thymus), brain, bladder, epididymis, and helper T cells, suggesting physiological relevance in the nervous, immune, and male reproductive systems[2]. Differential methylation and downregulation have been associated with pancreatic cancer, implicating it as a candidate biomarker, but direct roles in disease pathogenesis or as a drug target have not been established. While it is linked to hereditary pigmentary disorders, no drugs or mechanisms of action are currently attributed to this molecule[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 12 open reading frame 42 (C12orf42).